Christopher Goetz to Delayed-Action Preparations
This is a "connection" page, showing publications Christopher Goetz has written about Delayed-Action Preparations.
Connection Strength
0.089
-
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa. Neurology. 1989 Nov; 39(11 Suppl 2):63-6; discussion 72-3.
Score: 0.023
-
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Neurology. 1988 Jul; 38(7):1143-6.
Score: 0.021
-
Epidemiology and pathophysiology of tardive dyskinesias. Adv Neurol. 1988; 49:185-97.
Score: 0.020
-
Controlled-release Sinemet. Neurology. 1987 Sep; 37(9):1567-8.
Score: 0.020
-
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study. Clin Neuropharmacol. 1991 Aug; 14(4):322-9.
Score: 0.006